These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33120945)

  • 1. Recent Advances in Nanotherapeutics for Multiple Myeloma.
    Iannazzo D; Ettari R; Giofrè S; Eid AH; Bitto A
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33120945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External and Internal Stimuli-Responsive Metallic Nanotherapeutics for Enhanced Anticancer Therapy.
    Mohapatra A; Uthaman S; Park IK
    Front Mol Biosci; 2020; 7():597634. PubMed ID: 33505987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics.
    Nicol JR; Dixon D; Coulter JA
    Nanomedicine (Lond); 2015; 10(8):1315-26. PubMed ID: 25955125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in nanotherapeutics for the treatment and prevention of acute kidney injury.
    Yu H; Liu D; Shu G; Jin F; Du Y
    Asian J Pharm Sci; 2021 Jul; 16(4):432-443. PubMed ID: 34703493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress on nanoparticle-based drug delivery systems for cancer therapy.
    Xin Y; Yin M; Zhao L; Meng F; Luo L
    Cancer Biol Med; 2017 Aug; 14(3):228-241. PubMed ID: 28884040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart Nanotherapeutic Targeting of Tumor Vasculature.
    Li Z; Di C; Li S; Yang X; Nie G
    Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus.
    Majumder J; Minko T
    Adv Ther (Weinh); 2021 Feb; 4(2):2000203. PubMed ID: 33173809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promises of Nanotherapeutics in Obesity.
    Ash GI; Kim D; Choudhury M
    Trends Endocrinol Metab; 2019 Jun; 30(6):369-383. PubMed ID: 31126754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-leishmanial Nanotherapeutics: A Current Perspective.
    Shah A; Gupta SS
    Curr Drug Metab; 2019; 20(6):473-482. PubMed ID: 30360732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment.
    Kouchakzadeh H; Abbas Shojaosadati S
    Curr Pharm Des; 2016; 22(22):3455-65. PubMed ID: 26845324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy.
    Hussain Z; Arooj M; Malik A; Hussain F; Safdar H; Khan S; Sohail M; Pandey M; Choudhury H; Ei Thu H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1015-1024. PubMed ID: 29873531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs.
    Prados J; Melguizo C; Ortiz R; Perazzoli G; Cabeza L; Alvarez PJ; Rodriguez-Serrano F; Aranega A
    Anticancer Agents Med Chem; 2013 Oct; 13(8):1204-16. PubMed ID: 23574385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology for targeted cancer therapy.
    Wang MD; Shin DM; Simons JW; Nie S
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):833-7. PubMed ID: 17555393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy.
    Qiao Y; Wan J; Zhou L; Ma W; Yang Y; Luo W; Yu Z; Wang H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1527. PubMed ID: 29726115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical prediction of nanoparticle delivery: from culture media to cell.
    Brown MR; Hondow N; Brydson R; Rees P; Brown AP; Summers HD
    Nanotechnology; 2015 Apr; 26(15):155101. PubMed ID: 25797791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology as a potential therapeutic alternative for schistosomiasis.
    Tomiotto-Pellissier F; Miranda-Sapla MM; Machado LF; Bortoleti BTDS; Sahd CS; Chagas AF; Assolini JP; Oliveira FJA; Pavanelli WR; Conchon-Costa I; Costa IN; Melanda FN
    Acta Trop; 2017 Oct; 174():64-71. PubMed ID: 28668252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.
    Kanapathipillai M; Brock A; Ingber DE
    Adv Drug Deliv Rev; 2014 Dec; 79-80():107-18. PubMed ID: 24819216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology advances in brain tumors: the state of the art.
    Invernici G; Cristini S; Alessandri G; Navone SE; Canzi L; Tavian D; Redaelli C; Acerbi F; Parati EA
    Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):58-69. PubMed ID: 21110824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.